Retrospective study on characteristics and outcomes in hospitalised patients treated with Ondexxya

Trial Identifier:	D9603R00007
Sponsor:	AstraZeneca
Collaborator:	LOGEX Healthcare Analytics Amsterdam The Netherlands
NCTID::	NCT05898412
Start Date:	October 2023
Primary Completion Date:	June 2024
Study Completion Date:	June 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Netherlands	Amsterdam, Netherlands

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.